Skip to content

Projection · SCALE Obesity and Prediabetes

Saxenda weight loss from 240 lb

If you match the trial average at 3 mg, you'd be about 221 lb by week 56.

Clinician review pending Updated
Avg loss by week 56
−19lb
3 mg, 8.0%
Weight at week 56
221lb
if you match the average
Placebo group
−6lb
2.6%, same trial
Trial length
56weeks
SCALE Obesity and Prediabetes
Show the math
Loss = 240 lb × 8.0% = 19 lb
Projected weight from 240 lb
219225230236242091928374756weeks

Saxenda 3 mgPlacebo

Week by week

WeekSaxenda 3 mg
Week 4−4 lb · 236
Week 8−7 lb · 233
Week 12−10 lb · 230
Week 16−12 lb · 228
Week 24−15 lb · 225
Week 36−17 lb · 223
Week 52−19 lb · 221
Week 56−19 lb · 221

Pounds lost · weight. A curve shaped to the trial endpoint, not trial data for each week.

What each milestone means at 240 lb

LossPoundsNew weight
5%12 lb228 lb
10%24 lb216 lb
15%36 lb204 lb
20%48 lb192 lb
25%60 lb180 lb

About 63% lost at least 5% and about 33% lost at least 10%.

How this projection works

We take the average loss reported in SCALE Obesity and Prediabetes (3,731 adults with obesity or overweight, without diabetes) and fit a smooth curve that reaches it at week 56. Real progress is lumpier: early weeks include water, increases follow the dose steps, and individual results range widely around the average. Diet and activity changes were part of the trial for everyone, including placebo.

Other start weights

Common questions

How much weight can you lose on Saxenda at 240 lb?

If you matched the SCALE Obesity and Prediabetes average at 3 mg (8.0%), you'd lose about 19 lb over 56 weeks. Many people lose more or less.

How fast does Saxenda weight loss happen?

Loss is fastest in the first months and slows as you near the plateau. By week 24, the curve here shows about 15 lb at 3 mg.

Is this a guarantee?

No. It's an average from a trial, applied to your start weight. Your prescriber and your own weigh-ins are the real guide.

Sources

  1. Saxenda prescribing information (FDA label on DailyMed)
  2. SCALE Obesity and Prediabetes trial publication

Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error